ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $3.35bn
- $3.27bn
- $276.98m
Adaptive Biotechnologies Q3 revenue surges above estimates on MRD business growth
Brief: Adaptive Biotechnologies Q3 EPS USD 0.06
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: Adaptive Biotechnologies Q2 EPS USD -0.17
U.S. RESEARCH ROUNDUP-American Tower, GoDaddy, Labcorp
Adaptive Biotechnologies rises after quarterly sales beat
Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Edison International, Onestream, Vertex Pharmaceuticals
Adaptive Biotechnologies Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Adaptive Biotechnologies Q4 EPS USD -0.23
Brief: Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration
Brief: Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting
U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems
Adaptive Biotechnologies Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Adaptive Biotechnologies Q3 EPS USD -0.22
Brief: Adaptive Biotechnologies Receives Expanded Medicare Coverage Of Clonoseq For Assessing Measurable Residual Disease In Mantle Cell Lymphoma
U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins
Adaptive Biotechnologies Corp reports results for the quarter ended in June - Earnings Summary
Brief: Adaptive Biotechnologies Q2 EPS USD -0.31